Daniel Carpio

3.3k total citations
74 papers, 1.6k citations indexed

About

Daniel Carpio is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Daniel Carpio has authored 74 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Genetics, 32 papers in Surgery and 27 papers in Epidemiology. Recurrent topics in Daniel Carpio's work include Inflammatory Bowel Disease (37 papers), Microscopic Colitis (26 papers) and Helicobacter pylori-related gastroenterology studies (10 papers). Daniel Carpio is often cited by papers focused on Inflammatory Bowel Disease (37 papers), Microscopic Colitis (26 papers) and Helicobacter pylori-related gastroenterology studies (10 papers). Daniel Carpio collaborates with scholars based in Spain, Chile and United States. Daniel Carpio's co-authors include Marcelo Ezquer, Fernando Ezquer, Paulette Conget, Alejandro J. Yáñez, Sergio Mezzano, Marta Ruiz‐Ortega, Alejandra Droguett, Manuel Barreiro‐de Acosta, Jesús Egido and M. Eugenia Burgos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Daniel Carpio

71 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Carpio Spain 23 697 435 432 349 343 74 1.6k
Natalie Patey Canada 23 484 0.7× 255 0.6× 334 0.8× 96 0.3× 178 0.5× 65 1.7k
Francesca D’Addio Italy 28 791 1.1× 509 1.2× 405 0.9× 127 0.4× 209 0.6× 60 2.2k
Norihiro Sato Japan 15 659 0.9× 129 0.3× 360 0.8× 167 0.5× 282 0.8× 44 1.9k
Tiina Heliö Finland 24 316 0.5× 411 0.9× 650 1.5× 159 0.5× 313 0.9× 77 2.2k
JN George United States 18 421 0.6× 286 0.7× 394 0.9× 363 1.0× 78 0.2× 26 3.3k
Andrea Pasini Italy 23 169 0.2× 111 0.3× 378 0.9× 158 0.5× 191 0.6× 67 1.6k
Yasuyuki Nagasawa Japan 28 277 0.4× 812 1.9× 957 2.2× 124 0.4× 141 0.4× 100 2.6k
Regina Verani United States 22 301 0.4× 169 0.4× 341 0.8× 116 0.3× 91 0.3× 56 1.6k
Judy Maddox United States 15 503 0.7× 424 1.0× 2.0k 4.7× 99 0.3× 185 0.5× 19 3.7k
Αθανάσιος Παπαθεοδώρου Greece 22 296 0.4× 76 0.2× 460 1.1× 173 0.5× 196 0.6× 90 1.6k

Countries citing papers authored by Daniel Carpio

Since Specialization
Citations

This map shows the geographic impact of Daniel Carpio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Carpio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Carpio more than expected).

Fields of papers citing papers by Daniel Carpio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Carpio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Carpio. The network helps show where Daniel Carpio may publish in the future.

Co-authorship network of co-authors of Daniel Carpio

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Carpio. A scholar is included among the top collaborators of Daniel Carpio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Carpio. Daniel Carpio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marín‐Jiménez, Ignacio, Daniel Carpio, Vicent Hernández, et al.. (2025). Spanish Working Group in Crohn’s Disease and Ulcerative Colitis (GETECCU) position paper on cardiovascular disease in patients with inflammatory bowel disease. Gastroenterología y Hepatología (English Edition). 48(5). 502314–502314. 2 indexed citations
2.
Marín‐Jiménez, Ignacio, Daniel Carpio, Vicent Hernández, et al.. (2024). Documento de posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre la enfermedad cardiovascular en los pacientes con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología. 48(5). 502314–502314. 1 indexed citations
3.
Calvet, Xavier, Daniel Carpio, Iago Rodríguez–Lago, et al.. (2021). Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies. Gastroenterología y Hepatología (English Edition). 44(8). 587–598. 4 indexed citations
4.
Casellas, Francesc, et al.. (2021). Factors associated with quality of care in inflammatory bowel diseases: a view from patient’s side using the IQCARO quality of care decalogue. BMC Gastroenterology. 21(1). 412–412. 5 indexed citations
5.
Riestra, Sabino, Carlos Taxonera, Yamile Zabana, et al.. (2020). Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease. Gastroenterología y Hepatología (English Edition). 44(1). 51–66. 4 indexed citations
6.
Contador, David, Daniela Santapau, Lorena Lobos‐González, et al.. (2020). Human adipose-derived mesenchymal stem cell-conditioned medium ameliorates polyneuropathy and foot ulceration in diabetic BKS db/db mice. Stem Cell Research & Therapy. 11(1). 168–168. 87 indexed citations
7.
González‐Lama, Yago, Daniel Carpio, Manuel Barreiro‐de Acosta, et al.. (2020). Comparison of original and biosimilar infliximab (CTP-13) in biologic-na�ve patients with Crohn�s disease and ulcerative colitis: a retrospective, multicenter real-life study in Spain.. Revista Española de Enfermedades Digestivas. 113(3). 170–178. 2 indexed citations
8.
Calvet, Xavier, Federico Argüelles‐Arias, Antonio López–Sanromán, et al.. (2018). Patients' perceptions of the impact of ulcerative colitis on social and professional life: results from the UC-LIFE survey of outpatient clinics in Spain. SHILAP Revista de lepidopterología. 2 indexed citations
9.
Argüelles‐Arias, Federico, Daniel Carpio, Xavier Calvet, et al.. (2017). Knowledge of disease and access to a specialist reported by Spanish patients with ulcerative colitis. UC-LIFE survey. Revista Española de Enfermedades Digestivas. 109(6). 421–429. 4 indexed citations
10.
López–Sanromán, Antonio, Daniel Carpio, Xavier Calvet, et al.. (2016). Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey. Digestive Diseases and Sciences. 62(1). 207–216. 23 indexed citations
11.
Sánchez-Niño, María Dolores, Daniel Carpio, Ana B. Sanz, et al.. (2015). Lyso-Gb3 activates Notch1 in human podocytes. Human Molecular Genetics. 24(20). 5720–5732. 107 indexed citations
12.
Carpio, Daniel, et al.. (2015). Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain. European Journal of Gastroenterology & Hepatology. 27(9). 1030–1037. 9 indexed citations
13.
Bertinat, Romina, Daniel Carpio, María José Ramírez-Bajo, et al.. (2012). Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidney. Journal of Cellular Biochemistry. 114(3). 639–649. 59 indexed citations
14.
Acosta, Manuel Barreiro‐de, Ana Echarri, Daniel Carpio, et al.. (2011). A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease receiving Azathioprine.. PubMed. 20(3). 247–53. 37 indexed citations
15.
Flórez, Ángeles, et al.. (2011). Vitiligo during Treatment of Crohn’s Disease with Adalimumab: Adverse Effect or Co-Occurrence. SHILAP Revista de lepidopterología. 3(1). 28–31. 21 indexed citations
16.
Echarri, Ana, et al.. (2010). Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure. Journal of Crohn s and Colitis. 4(6). 654–660. 27 indexed citations
17.
Ezquer, Fernando, Marcelo Ezquer, Valeska Simon, et al.. (2009). Endovenous Administration of Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells Prevents Renal Failure in Diabetic Mice. Biology of Blood and Marrow Transplantation. 15(11). 1354–1365. 86 indexed citations
18.
Álvarez, Victoria, et al.. (2005). Upper Gastrointestinal Bleeding in a Patient With a Balloon Bumper PEG Feeding Tube. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 15(2). 94–94. 1 indexed citations
19.
Gisbert, Javier P., Javier Fuentes, Daniel Carpio, et al.. (2005). 7‐day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure. Alimentary Pharmacology & Therapeutics. 21(10). 1249–1253. 10 indexed citations
20.
Gisbert, Javier P., et al.. (2000). One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. European Journal of Gastroenterology & Hepatology. 12(5). 489–495. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026